---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-016854"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T00:45:56.382408+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q2 revenue surges 175% to $3.9M; net loss improves to $0.17/share

## Summary
- Q2 revenue $3.9M vs $1.4M a year ago, driven by Zola and GoodWheat pasta launch.
- Net loss attributable to common stockholders narrowed 28% to $3.8M ($0.17 per share) from $5.3M.
- First-half 2022 revenue $7.1M, up 217%; net loss $8.3M vs $3.2M, impacted by absence of $10.2M gain on Bioceres stock in 2021.
- Received $2M milestone from Bioceres for HB4 soybean approval in China; part recognized as license revenue.
- Introduced Project Greenfield, a 3-year plan aiming for profitability, focusing on core brands.

## SEC filing metadata
- accession: 0000950170-22-016854
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017022016854/0000950170-22-016854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017022016854/rkda-20220811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-016854
- JSON: https://secwatch.observer/filing/0000950170-22-016854.json
- Plain text: https://secwatch.observer/filing/0000950170-22-016854.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.